About: Repligen

Property	Value
dbo:abstract	Repligen is an American company devoted to the development and production of materials used in the manufacture of biological drugs. The company is based in Waltham, Massachusetts, and incorporated in Delaware in 1981. A public company, Repligen is listed on the NASDAQ exchange under the symbol RGEN. As of February 2014, Repligen employed 116 people, about 50% of these based in Sweden. (en)
dbo:assets	1.19E8
dbo:equity	1.04E8
dbo:foundedBy	dbr:Paul_Schimmel dbr:Alexander_Rich
dbo:foundingYear	1981-01-01 (xsd:gYear)
dbo:numberOfEmployees	116 (xsd:nonNegativeInteger)
dbo:operatingIncome	2.3E7
dbo:revenue	6.8E7
dbo:type	dbr:Public_company
dbo:wikiPageExternalLink	http://corporate.repligen.com/file.aspx%3FIID=4325751&FID=22568361&O=3&OSID=9 http://www.fool.com/quote/nasdaq/repligen-corp/rgen/key-executives https://www.repligen.com https://web.archive.org/web/20140315184535/http:/topics.nytimes.com/top/news/business/companies/repligen-corporation/ https://web.archive.org/web/20140315192553/http:/www.forbes.com/profile/alexander-rich/ https://web.archive.org/web/20140315194147/http:/www.fool.com/quote/nasdaq/repligen-corp/rgen/key-executives https://web.archive.org/web/20140315195141/http:/www.streetinsider.com/Management+Changes/Repligen+(RGEN)+Replaces+Board+Member+Alex+Rich+with+Alfred+Goldberg/6796218.html https://www.forbes.com/profile/alexander-rich/ http://topics.nytimes.com/top/news/business/companies/repligen-corporation/ http://www.streetinsider.com/Management+Changes/Repligen+(RGEN)+Replaces+Board+Member+Alex+Rich+with+Alfred+Goldberg/6796218.html
dbo:wikiPageID	42211934 (xsd:integer)
dbo:wikiPageLength	12559 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID	1102538891 (xsd:integer)
dbo:wikiPageWikiLink	dbr:Protein_A dbr:Royalties dbr:New_Drug_Application dbr:BioMarin_Pharmaceutical dbr:Board_of_Directors dbr:Paul_Schimmel dbr:Pfizer dbr:United_States_dollar dbr:University_of_Michigan dbr:Delaware_General_Corporation_Law dbr:Project_finance dbr:Public_company dbc:Companies_listed_on_the_Nasdaq dbr:S&P_400 dbr:Chief_executive_officer dbr:Gen._Eng._Biotechnol._News dbr:NASDAQ dbr:Cross-flow_filtration dbr:The_Motley_Fool dbr:Lund dbr:MIT dbr:Clinical_trial dbr:Column_chromatography dbr:Friedreich's_ataxia dbr:Bristol-Myers_Squibb dbr:CEO dbr:USFDA dbr:Waltham,_Massachusetts dbr:Alexander_Rich dbc:Companies_based_in_Massachusetts dbr:European_Medicines_Agency dbr:Forbes dbr:Novozymes dbc:Manufacturing_support_companies dbr:Form_10-K dbr:Histone_deacetylase_inhibitor dbr:President_(corporate_title) dbc:1981_establishments_in_Massachusetts dbr:Bioproduction dbr:Swedish_krona dbr:Marketing_Authorization_Application dbr:Spinal_muscular_atrophy dbr:Contrast_medium dbr:Growth_factor dbr:Incorporation_(business) dbr:Intermediary dbr:Exchange_rate dbr:International_New_York_Times dbr:RG3039 dbr:Orencia dbr:The_Scripps_Research_Institute dbr:Direct_sales dbr:Company_president dbr:Biological_drug dbr:Exclusive_license dbr:Wikt:emeritus dbr:TangenX
dbp:assets	1.19E8
dbp:bloomberg	RGEN:US (en)
dbp:date	August 2022 (en)
dbp:equity	1.04E8
dbp:founders	Alexander Rich (en) Paul Schimmel (en)
dbp:google	RGEN:NASDAQ (en)
dbp:homepage	https://www.repligen.com
dbp:industry	Pharmaceutical industry (en)
dbp:keyPeople	Tony J. Hunt (en)
dbp:locationCity	Waltham, Massachusetts (en)
dbp:locationCountry	United States (en)
dbp:name	Repligen Corporation (en)
dbp:numEmployees	116 (xsd:integer)
dbp:operatingIncome	2.3E7
dbp:part	Entire article (en)
dbp:products	Materials used in the manufacture of biological drugs (en)
dbp:reason	hasn't been materially touched since 2014 (en)
dbp:reuters	RGEN.O (en)
dbp:revenue	6.8E7
dbp:secCik	730272 (xsd:integer)
dbp:symbol	RGEN (en)
dbp:tradedAs	dbr:S&P_400 NASDAQ:RGEN (en)
dbp:type	dbr:Public_company
dbp:wikiPageUsesTemplate	dbt:As_of dbt:Authority_control dbt:Citation dbt:Cite_news dbt:Cite_web dbt:Increase dbt:Infobox_company dbt:Official dbt:Ref dbt:Reflist dbt:Sfn dbt:Short_description dbt:Small dbt:Start_date_and_age dbt:Update dbt:Harvid dbt:Finance_links
dbp:yahoo	RGEN (en)
dcterms:subject	dbc:Companies_listed_on_the_Nasdaq dbc:Companies_based_in_Massachusetts dbc:Manufacturing_support_companies dbc:1981_establishments_in_Massachusetts
gold:hypernym	dbr:Company
rdf:type	owl:Thing dbo:Company schema:Organization dul:Agent dul:SocialPerson dbo:Agent wikidata:Q24229398 wikidata:Q43229 wikidata:Q4830453 yago:WikicatCompaniesBasedInMassachusetts yago:WikicatCompaniesListedOnNASDAQ yago:WikicatManufacturingSupportCompanies yago:Abstraction100002137 yago:Company108058098 yago:Group100031264 yago:Institution108053576 yago:Organization108008335 yago:YagoLegalActor yago:YagoLegalActorGeo yago:YagoPermanentlyLocatedEntity dbo:Organisation yago:SocialGroup107950920
rdfs:comment	Repligen is an American company devoted to the development and production of materials used in the manufacture of biological drugs. The company is based in Waltham, Massachusetts, and incorporated in Delaware in 1981. A public company, Repligen is listed on the NASDAQ exchange under the symbol RGEN. As of February 2014, Repligen employed 116 people, about 50% of these based in Sweden. (en)
rdfs:label	Repligen (en)
owl:sameAs	freebase:Repligen yago-res:Repligen wikidata:Repligen https://global.dbpedia.org/id/fWRZ
skos:closeMatch	http://www.grid.ac/institutes/grid.419042.a
prov:wasDerivedFrom	wikipedia-en:Repligen?oldid=1102538891&ns=0
foaf:homepage	https://www.repligen.com
foaf:isPrimaryTopicOf	wikipedia-en:Repligen
foaf:name	Repligen Corporation (en)
is dbo:wikiPageRedirects of	dbr:OPUS_(chromatography) dbr:RG1068 dbr:Repligen_Corp
is dbo:wikiPageWikiLink of	dbr:BioMarin_Pharmaceutical dbr:List_of_pharmaceutical_companies dbr:Roberta_Farrell dbr:OPUS_(chromatography) dbr:Repligen_Corporation_Award_in_Chemistry_of_Biological_Processes dbr:Cross-flow_filtration dbr:Alexander_Rich dbr:List_of_S&P_400_companies dbr:Spinal_muscular_atrophy dbr:Russell_1000_Index dbr:RG1068 dbr:Repligen_Corp
is foaf:primaryTopic of	wikipedia-en:Repligen